Garadacimab
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Garadacimab, covering 2023-06-29 to 2026-06-02. Get the full timeline:
Most recent: Clinical Trial Results: Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks [Phase 3]